Research work · 2016
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
Scott Joseph Antonia, Sarah B. Goldberg, Ani Sarkis Balmanoukian, Jamie E. Chaft, Rachel E. Sanborn, Ashok Kumar Gupta, Rajesh Narwal, Keith E. Steele, Yu Lan Gu, Joyson Joseph Karakunnel, Naiyer A. Rizvi
The Lancet Oncology